Kira Pharmaceuticals, a developer of therapies to treat immune-mediated diseases, has secured $46 million in funding. The backers included Quan Capital, 6 Dimensions Capital, Qiming Venture Partners and Sinopharm Capital.
Source: Press Release
Kira Pharmaceuticals lands $46m
Kira Pharmaceuticals, a developer of therapies to treat immune-mediated diseases, has secured $46 million in funding.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: